Mitophagy in depression: Pathophysiology and treatment targets
- PMID: 34478906
- PMCID: PMC8962570
- DOI: 10.1016/j.mito.2021.08.016
Mitophagy in depression: Pathophysiology and treatment targets
Abstract
Mitochondria, the 'powerhouse' of eukaryotic cells, play a key role in cellular homeostasis. However, defective mitochondria increase mitochondrial ROS (mtROS) production and cell-free mitochondrial DNA (mtDNA) release, leading to increased inflammation. Mitophagy is a vital pathway, which selectively removes defective mitochondria through the process of autophagy. Thus, an impairment in the mitophagy pathway might trigger the gradual accumulation of defective mitochondria. Accumulating evidence suggest that inflammation and mitochondrial dysfunction are linked to the pathogenesis of depression. In this article, we have reviewed the role of impaired mitophagy as a contributing factor in depression pathophysiology. Further, we have discussed the potential therapeutic interventions aimed at modulating mitophagy in depression.
Keywords: Depression; Mitochondria; Mitophagy; Therapeutics.
Published by Elsevier B.V.
Figures

References
-
- Archibald JM. Endosymbiosis and Eukaryotic Cell Evolution. Curr Biol. 2015. Oct 5;25(19):R911–21. - PubMed
-
- Sagan L On the origin of mitosing cells. J Theor Biol. 1967. Mar;14(3):255–74. - PubMed
-
- Roger AJ, Munoz-Gomez SA, Kamikawa R. The Origin and Diversification of Mitochondria. Curr Biol. 2017. Nov 6;27(21):R1177–R1192. - PubMed
-
- Cerveny KL, Tamura Y, Zhang Z, et al. Regulation of mitochondrial fusion and division. Trends Cell Biol. 2007. Nov;17(11):563–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical